| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1041424735 |
| P356 | DOI | 10.1186/1745-0179-1-21 |
| P932 | PMC publication ID | 1283978 |
| P698 | PubMed publication ID | 16216125 |
| P5875 | ResearchGate publication ID | 7550031 |
| P50 | author | Bernardo Dell'Osso | Q56482061 |
| Eric Hollander | Q107871887 | ||
| P2093 | author name string | Andrea Allen | |
| P2860 | cites work | A rating scale for depression | Q24564540 |
| The assessment of anxiety states by rating | Q29614719 | ||
| Changes in brain glucose metabolism in cocaine dependence and withdrawal | Q30053999 | ||
| Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design | Q33180244 | ||
| 5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward. | Q52248872 | ||
| Alcoholism, drug abuse, and gambling. | Q52493129 | ||
| An open trial of valproate in borderline personality disorder | Q54001001 | ||
| Lithium and lady luck; use of lithium carbonate in compulsive gambling. | Q54298197 | ||
| A double-blind trial of fluoxetine in pathologic skin picking | Q56910494 | ||
| Pathological gamblers--will they use a new telephone hotline? | Q57118920 | ||
| Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis | Q60142213 | ||
| Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area | Q66967828 | ||
| The compulsive gambler's spiral of options and involvement | Q67465870 | ||
| Nosological classifications of obsessive-compulsive disorder | Q67799371 | ||
| Lithium treatment of chronic hair pulling | Q67984993 | ||
| Pathological gambling among youthful multiple substance abusers in a therapeutic community | Q67998515 | ||
| Treatment of pathological gambling with clomipramine | Q68109459 | ||
| Depressed pathological gamblers | Q68338953 | ||
| Pharmacological treatment of kleptomania and bulimia nervosa | Q69542665 | ||
| Affective disorders among pathological gamblers seeking treatment | Q71254283 | ||
| Reinforcing effects of morphine microinjection into the ventral tegmental area | Q71277951 | ||
| Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine | Q71334741 | ||
| Behavioral effects of naloxone infusion in obsessive-compulsive disorder | Q71501753 | ||
| The effect of a 5-HT3 receptor antagonist, ondansetron, on brain stimulation reward, and its interaction with direct and indirect stimulants of central dopaminergic transmission | Q72957854 | ||
| Response of kleptomania and mixed mania to valproate | Q73196341 | ||
| A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling | Q73794738 | ||
| Naltrexone in the treatment of pathological gambling and alcohol dependence | Q74290952 | ||
| Updating and refining prevalence estimates of disordered gambling behaviour in the United States and Canada | Q74341494 | ||
| Short-term single-blind fluvoxamine treatment of pathological gambling | Q77646710 | ||
| Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness | Q33880704 | ||
| Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling | Q33948583 | ||
| Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial | Q33964132 | ||
| Pathological gambling | Q34032774 | ||
| A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling | Q34135868 | ||
| Naltrexone in the treatment of alcohol dependence | Q34241680 | ||
| Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? | Q34380515 | ||
| A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder | Q34522077 | ||
| Diagnosis and treatment of pathologic gambling | Q35103438 | ||
| The epidemiology and differential diagnosis of obsessive compulsive disorder | Q36004140 | ||
| Suicidal ideation and suicide attempts in treatment-seeking pathological gamblers. | Q36096840 | ||
| Functional anatomy of obsessive-compulsive phenomena | Q39171635 | ||
| Gambling among methadone patients | Q39371898 | ||
| Epidemiology of gambling and depression in an adult sample | Q39396006 | ||
| Physiological changes in Pachinko players; beta-endorphin, catecholamines, immune system substances and heart rate | Q40636826 | ||
| An open-label study of citalopram in the treatment of pathological gambling | Q40661279 | ||
| Insights about pathological gamblers. 'Chasing losses' in spite of the consequences | Q40890493 | ||
| Compulsive buying: a review | Q41027225 | ||
| Diagnosis, neurobiology, and treatment of pathological gambling. | Q41027250 | ||
| Effect of the 5-HT3 receptor antagonists, MDL72222 and ondansetron on morphine place conditioning | Q41112162 | ||
| Are impulse-control disorders related to bipolar disorder? | Q41127483 | ||
| An open-label study of naltrexone in the treatment of kleptomania | Q42675960 | ||
| Divalproex sodium for impulsive aggressive behavior in patients with personality disorder. | Q42690745 | ||
| Opioid antagonists in the treatment of impulse-control disorders. | Q43071046 | ||
| A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. | Q43577338 | ||
| Psychiatric comorbidity in pathological gamblers seeking treatment. | Q43752234 | ||
| A pilot placebo-controlled study of fluvoxamine for pathological gambling. | Q44015745 | ||
| Lithium and valproate treatment of pathological gambling: a randomized single-blind study. | Q44080281 | ||
| Pathological gambling: a clinical and therapeutic-evolutive study of a group of pathologic gamblers | Q44193255 | ||
| Nefazodone treatment of pathological gambling: a prospective open-label controlled trial. | Q44224606 | ||
| Divalproex in the Treatment of Impulsive Aggression: Efficacy in Cluster B Personality Disorders | Q44407169 | ||
| Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial | Q44484632 | ||
| An open-label trial of bupropion in the treatment of pathologic gambling | Q44717931 | ||
| Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study | Q45265367 | ||
| Pathological gambling and major affective disorder: preliminary findings. | Q45296309 | ||
| Pathological gambling in hospitalized substance abusing veterans. | Q45335495 | ||
| Personality profiles of hospitalized pathological gamblers: the California Personality Inventory | Q46148042 | ||
| 5-HT3 receptor antagonists inhibit morphine-induced stimulation of mesolimbic dopamine release and function in the rat. | Q48347747 | ||
| Effects of morphine and naloxone on thresholds of ventral tegmental electrical self-stimulation | Q48463733 | ||
| Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area | Q48663508 | ||
| An open naltrexone treatment study in pathological gambling disorder | Q48664762 | ||
| Pathological gambling and platelet MAO activity: a psychobiological study. | Q51046522 | ||
| Divalproex treatment of disruptive adolescents: a report of 10 cases. | Q51107943 | ||
| Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial. | Q51113845 | ||
| Treatment of pathological gambling with carbamazepine. | Q52026507 | ||
| SCL-90 Assessed Psychopathology in Pathological Gamblers | Q52070592 | ||
| Blockade of acquisition of drug-conditioned place aversion by 5HT3 antagonists. | Q52242866 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| comorbidity | Q1414874 | ||
| problem gambling | Q748309 | ||
| P304 | page(s) | 21 | |
| P577 | publication date | 2005-10-10 | |
| P1433 | published in | Clinical Practice and Epidemiology in Mental Health | Q15762194 |
| P1476 | title | Comorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review. | |
| P478 | volume | 1 |
| Q51862925 | Comorbidity in pathological gambling: clinical variables, personality and treatment response. |
| Q44363336 | Does exposure and response prevention improve the results of group cognitive-behavioural therapy for male slot machine pathological gamblers? |
| Q24669677 | Epidemiologic and clinical updates on impulse control disorders: a critical review |
| Q41078341 | Gambling disorder: Association between duration of illness, clinical, and neurocognitive variables. |
| Q57448046 | Gambling in Great Britain: A Response to Rogers |
| Q35574495 | Pathological gambling: a review of phenomenological models and treatment modalities for an underrecognized psychiatric disorder |
| Q37056593 | Pathological gambling: an update on neuropathophysiology and pharmacotherapy |
| Q64910100 | Pharmacological Treatments for Disordered Gambling: A Meta-analysis. |
| Q33735862 | Pharmacological treatments in gambling disorder: a qualitative review. |
| Q33582039 | Pharmacological treatments in pathological gambling |
| Q36688997 | Pharmacotherapy of pathological gambling: review of new treatment modalities |
| Q52290496 | Temperament and character in pathological gambling. |
| Q41484586 | The Relationship Between Problem Gambling and Attention Deficit Hyperactivity Disorder |
| Q37210109 | Volitional disorders: a proposal for DSM-V. |
| Q52295145 | [Gambling and internet addiction: review and research agenda]. |
Search more.